Neuropeptides as Targets for the Development of Anticonvulsant Drugs (original) (raw)

• Weaver DF, Pohlmann-Eden B (2013) Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s). Epilepsia 54(Suppl 2):80–85
  PubMed CAS Google Scholar
• Dobolyi A, Kekesi KA, Juhasz G, Szekely AD, Lovas G, Kovacs Z (2014) Receptors of peptides as therapeutic targets in epilepsy research. Curr Med Chem 21:764–787
  PubMed CAS Google Scholar
• Kovac S, Walker MC (2013) Neuropeptides in epilepsy. Neuropeptides 47:467–475
  PubMed CAS Google Scholar
• Mytinger JR, Joshi S (2012) The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. J Child Neurol 27:1289–1294
  PubMed Google Scholar
• Tsao CY (2009) Current trends in the treatment of infantile spasms. Neuropsychiatr Dis Treat 5:289–299
  PubMed CAS PubMed Central Google Scholar
• Matsumoto A, Kumagai T, Takeuchi T, Miyazaki S, Watanabe K (1987) Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy. Epilepsia 28:49–55
  PubMed CAS Google Scholar
• Takeuchi Y, Takano T, Abe J, Takikita S, Ohno M (2001) Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies. Brain Dev 23:662–667
  PubMed CAS Google Scholar
• Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804–5812
  PubMed CAS Google Scholar
• Cardoso A, Freitas-da-Costa P, Carvalho LS, Lukoyanov NV (2010) Seizure-induced changes in neuropeptide Y-containing cortical neurons: Potential role for seizure threshold and epileptogenesis. Epilepsy Behav 19:559–567
  PubMed Google Scholar
• Poulsen FR, Jahnsen H, Blaabjerg M, Zimmer J (2002) Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures. Brain Res 950:103–118
  PubMed CAS Google Scholar
• Vezzani A, Schwarzer C, Lothman EW, Williamson J, Sperk G (1996) Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res 26:267–279
  PubMed CAS Google Scholar
• de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495:387–395
  PubMed Google Scholar
• Gobbi M, Gariboldi M, Piwko C, Hoyer D, Sperk G, Vezzani A (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 70:1615–1622
  PubMed CAS Google Scholar
• Kofler N, Kirchmair E, Schwarzer C, Sperk G (1997) Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci Lett 230:129–132
  PubMed CAS Google Scholar
• Schwarzer C, Kofler N, Sperk G (1998) Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53:6–13
  PubMed CAS Google Scholar
• Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415–421
  PubMed CAS Google Scholar
• Vezzani A, Michalkiewicz M, Michalkiewicz T, Moneta D, Ravizza T, Richichi C, Aliprandi M, Mule F, Pirona L, Gobbi M, Schwarzer C, Sperk G (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110:237–243
  PubMed CAS Google Scholar
• Noé F, Frasca A, Balducci C, Carli M, Sperk G, Ferraguti F, Pitkänen A, Bland R, Fitzsimons H, During M, Vezzani A (2009) Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics 6:300–306
  PubMed Google Scholar
• Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24:3051–3059
  PubMed CAS Google Scholar
• Bacci A, Huguenard JR, Prince DA (2002) Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc Natl Acad Sci U S A 99:17125–17130
  PubMed CAS PubMed Central Google Scholar
• Baraban SC (2004) Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides 38:261–265
  PubMed CAS Google Scholar
• El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, Gehlert DR, Vezzani A, Colmers WF (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22:1417–1430
  PubMed Google Scholar
• Guo H, Castro PA, Palmiter RD, Baraban SC (2002) Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J Neurophysiol 87:558–566
  PubMed CAS Google Scholar
• Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, Wong H, Walsh JH, Hokfelt T (2002) Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 111:443–532
  PubMed CAS Google Scholar
• Meurs A, Clinckers R, Ebinger G, Michotte Y, Smolders I (2007) Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur J Neurosci 26:3079–3092
  PubMed Google Scholar
• Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2004) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem 89:834–843
  PubMed CAS Google Scholar
• Woldbye DP, Kokaia M (2004) Neuropeptide Y and seizures: effects of exogenously applied ligands. Neuropeptides 38:253–260
  PubMed CAS Google Scholar
• Meurs A, Clinckers R, Ebinger G, Michotte Y, Smolders I (2007) Clinical potential of neuropeptide Y receptor ligands in the treatment of epilepsy. Curr Top Med Chem 7:1660–1674
  PubMed CAS Google Scholar
• Dubé C, Brunson KL, Eghbal-Ahmadi M, Gonzalez-Vega R, Baram TZ (2005) Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. J Mol Neurosci 25:275–284
  PubMed PubMed Central Google Scholar
• French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, Spencer DD (1993) Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 34:774–780
  PubMed CAS Google Scholar
• Cendes F, Andermann F, Dubeau F, Gloor P, Evans A, Jones-Gotman M, Olivier A, Andermann E, Robitaille Y, Lopes-Cendes I (1993) Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 43:1083–1087
  PubMed CAS Google Scholar
• Lin LC, Lee WT, Chen IJ, Yang RC (2010) Lower plasma neuropeptide Y level in patients with atypical febrile convulsions. Kaohsiung J Med Sci 26:8–12
  PubMed Google Scholar
• Mahyar A, Ayazi P, Nazari M, Sarokhani HR, Daneshi-Kohan MM, Javadi A (2013) Lack of correlation between plasma neuropeptide Y and typical and atypical febrile seizures. Acta Med Iran 51:246–249
  PubMed Google Scholar
• Howell OW, Silva S, Scharfman HE, Sosunov AA, Zaben M, Shatya A, McKhann G, Herzog H, Laskowski A, Gray WP (2007) Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol Dis 26:174–188
  PubMed CAS Google Scholar
• Kokaia M (2011) Seizure-induced neurogenesis in the adult brain. Eur J Neurosci 33:1133–1138
  PubMed Google Scholar
• Lerner JT, Sankar R, Mazarati AM (2008) Galanin and epilepsy. Cell Mol Life Sci 65:1864–1871
  PubMed CAS Google Scholar
• Mazarati AM (2004) Galanin and galanin receptors in epilepsy. Neuropeptides 38:331–343
  PubMed CAS Google Scholar
• Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18:10070–10077
  PubMed CAS Google Scholar
• Mazarati AM, Halaszi E, Telegdy G (1992) Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 589:164–166
  PubMed CAS Google Scholar
• Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG (2000) Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20:6276–6281
  PubMed CAS Google Scholar
• Chepurnov SA, Chepurnova NE, Abbasova KR, Smirnova MP (1997) The neuropeptide galanin and the seizure reactions of the developing brain. Usp Fiziol Nauk 28:3–20
  CAS Google Scholar
• Jacoby AS, Hort YJ, Constantinescu G, Shine J, Iismaa TP (2002) Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity. Brain Res Mol Brain Res 107:195–200
  PubMed CAS Google Scholar
• McColl CD, Jacoby AS, Shine J, Iismaa TP, Bekkers JM (2006) Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus. Neuropharmacology 50:209–218
  PubMed CAS Google Scholar
• Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T (2004) Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci 19:3235–3244
  PubMed Google Scholar
• Zini S, Roisin MP, Langel U, Bartfai T, Ben-Ari Y (1993) Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol 245:1–7
  PubMed CAS Google Scholar
• Zini S, Roisin MP, Armengaud C, Ben-Ari Y (1993) Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices. Neurosci Lett 153:202–205
  PubMed CAS Google Scholar
• Palazzi E, Felinska S, Zambelli M, Fisone G, Bartfai T, Consolo S (1991) Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. J Neurochem 56:739–747
  PubMed CAS Google Scholar
• Mazarati AM, Baldwin RA, Shinmei S, Sankar R (2005) In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J Neurochem 95:1495–1503
  PubMed CAS PubMed Central Google Scholar
• Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ (2003) Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18:2087–2092
  PubMed Google Scholar
• McCown TJ (2009) Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity. Neurotherapeutics 6:307–311
  PubMed CAS PubMed Central Google Scholar
• Ferrini F, Salio C, Lossi L, Merighi A (2009) Ghrelin in central neurons. Curr Neuropharmacol 7:37–49
  PubMed CAS PubMed Central Google Scholar
• Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48:23–29
  PubMed CAS Google Scholar
• Portelli J, Michotte Y, Smolders I (2012) Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia 53:585–595
  PubMed CAS Google Scholar
• Ataie Z, Golzar MG, Babri S, Ebrahimi H, Mohaddes G (2011) Does ghrelin level change after epileptic seizure in rats? Seizure 20:347–349
  PubMed CAS Google Scholar
• Gahete MD, Cordoba-Chacon J, Salvatori R, Castano JP, Kineman RD, Luque RM (2010) Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol 317:154–160
  PubMed CAS PubMed Central Google Scholar
• Bhatt R, Bhatt S, Rameshwar P, Siegel A (2005) Long-term kindled seizures induce alterations in hematopoietic functions: role of serum leptin. Epilepsy Res 65:169–178
  PubMed CAS Google Scholar
• Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337–345
  PubMed CAS Google Scholar
• Obay BD, Tasdemir E, Tumer C, Bilgin HM, Sermet A (2007) Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides 28:1214–1219
  PubMed CAS Google Scholar
• Biagini G, Torsello A, Marinelli C, Gualtieri F, Vezzali R, Coco S, Bresciani E, Locatelli V (2011) Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus. Eur J Pharmacol 670:130–136
  PubMed CAS Google Scholar
• Portelli J, Thielemans L, Ver Donck L, Loyens E, Coppens J, Aourz N, Aerssens J, Vermoesen K, Clinckers R, Schallier A, Michotte Y, Moechars D, Collingridge GL, Bortolotto ZA, Smolders I (2012) Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents. Neurotherapeutics 9:658–672
  PubMed CAS PubMed Central Google Scholar
• Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649–661
  PubMed CAS Google Scholar
• Moon M, Kim S, Hwang L, Park S (2009) Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr J 56:525–531
  PubMed CAS Google Scholar
• Xu J, Wang S, Lin Y, Cao L, Wang R, Chi Z (2009) Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett 453:58–61
  PubMed CAS Google Scholar
• Lee J, Lim E, Kim Y, Li E, Park S (2010) Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Endocrinol 205:263–270
  PubMed CAS Google Scholar
• Zhang R, Yang G, Wang Q, Guo F, Wang H (2013) Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis. Mol Biol Rep 40:51–58
  PubMed Google Scholar
• Vezzani A, Hoyer D (1999) Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci 11:3767–3776
  PubMed CAS Google Scholar
• Tallent MK, Qiu C (2008) Somatostatin: an endogenous antiepileptic. Mol Cell Endocrinol 286:96–103
  PubMed CAS PubMed Central Google Scholar
• De Bundel D, Aourz N, Kiagiadaki F, Clinckers R, Hoyer D, Kastellakis A, Michotte Y, Thermos K, Smolders I (2010) Hippocampal sst(1) receptors are autoreceptors and do not affect seizures in rats. Neuroreport 21:254–258
  PubMed Google Scholar
• Choi YS, Lin SL, Lee B, Kurup P, Cho HY, Naegele JR, Lombroso PJ, Obrietan K (2007) Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase. J Neurosci 27:2999–3009
  PubMed CAS PubMed Central Google Scholar
• Buckmaster PS, Dudek FE (1997) Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol 385:385–404
  PubMed CAS Google Scholar
• Sun C, Mtchedlishvili Z, Bertram EH, Erisir A, Kapur J (2007) Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation-based animal model of temporal lobe epilepsy. J Comp Neurol 500:876–893
  PubMed PubMed Central Google Scholar
• Halabisky B, Parada I, Buckmaster PS, Prince DA (2010) Excitatory input onto hilar somatostatin interneurons is increased in a chronic model of epilepsy. J Neurophysiol 104:2214–2223
  PubMed PubMed Central Google Scholar
• Zhang W, Yamawaki R, Wen X, Uhl J, Diaz J, Prince DA, Buckmaster PS (2009) Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. J Neurosci 29:14247–14256
  PubMed CAS PubMed Central Google Scholar
• Nagaki S, Nagaki S, Minatogawa Y, Sadamatsu M, Kato N, Osawa M, Fukuyama Y (1996) The role of vasopressin, somatostatin and GABA in febrile convulsion in rat pups. Life Sci 58:2233–2242
  PubMed CAS Google Scholar
• Schwarzer C, Sperk G, Samanin R, Rizzi M, Gariboldi M, Vezzani A (1996) Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res Brain Res Rev 22:27–50
  PubMed CAS Google Scholar
• Hashimoto T, Obata K (1991) Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus. Neurosci Res 12:514–527
  PubMed CAS Google Scholar
• Vezzani A, Monno A, Rizzi M, Galli A, Barrios M, Samanin R (1992) Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience 51:41–46
  PubMed CAS Google Scholar
• Marti M, Bregola G, Morari M, Gemignani A, Simonato M (2000) Somatostatin release in the hippocampus in the kindling model of epilepsy: a microdialysis study. J Neurochem 74:2497–2503
  PubMed CAS Google Scholar
• Hirai K, Seki T (2000) Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children. Neuropeptides 34:18–24
  PubMed CAS Google Scholar
• Csaba Z, Richichi C, Bernard V, Epelbaum J, Vezzani A, Dournaud P (2004) Plasticity of somatostatin and somatostatin sst2A receptors in the rat dentate gyrus during kindling epileptogenesis. Eur J Neurosci 19:2531–2538
  PubMed Google Scholar
• Perez J, Vezzani A, Civenni G, Tutka P, Rizzi M, Schupbach E, Hoyer D (1995) Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience 65:1087–1097
  PubMed CAS Google Scholar
• Vezzani A, Serafini R, Stasi MA, Vigano G, Rizzi M, Samanin R (1991) A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology 30:345–352
  PubMed CAS Google Scholar
• Monno A, Rizzi M, Samanin R, Vezzani A (1993) Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res 602:148–152
  PubMed CAS Google Scholar
• Mazarati AM, Telegdy G (1992) Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 31:793–797
  PubMed CAS Google Scholar
• Tallent MK, Siggins GR (1997) Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J Neurophysiol 78:3008–3018
  PubMed CAS Google Scholar
• Kozhemyakin M, Rajasekaran K, Todorovic MS, Kowalski SL, Balint C, Kapur J (2013) Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus. Neurobiol Dis 54:94–104
  PubMed CAS PubMed Central Google Scholar
• Aourz N, De Bundel D, Stragier B, Clinckers R, Portelli J, Michotte Y, Smolders I (2011) Rat hippocampal somatostatin sst3 and sst4 receptors mediate anticonvulsive effects in vivo: indications of functional interactions with sst2 receptors. Neuropharmacology 61:1327–1333
  PubMed CAS Google Scholar
• Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D, Nunn C, Hoyer D, Epelbaum J, Vezzani A (2002) Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci 16:843–849
  PubMed CAS Google Scholar
• Qiu C, Zeyda T, Johnson B, Hochgeschwender U, de Lecea L, Tallent MK (2008) Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. J Neurosci 28:3567–3576
  PubMed CAS Google Scholar
• Calbet M, Guadano-Ferraz A, Spier AD, Maj M, Sutcliffe JG, Przewlocki R, de Lecea L (1999) Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate. Brain Res Mol Brain Res 72:55–64
  PubMed CAS Google Scholar
• Wilson DN, Chung H, Elliott RC, Bremer E, George D, Koh S (2005) Microarray analysis of postictal transcriptional regulation of neuropeptides. J Mol Neurosci 25:285–298
  PubMed CAS Google Scholar
• Braun H, Schulz S, Becker A, Schroder H, Hollt V (1998) Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Res 803:54–60
  PubMed CAS Google Scholar
• Arganaraz GA, Konno AC, Perosa SR, Santiago JF, Boim MA, Vidotti DB, Varella PP, Costa LG, Canzian M, Porcionatto MA, Yacubian EM, Sakamoto AC, Jr Carrete H, Centeno RS, Amado D, Cavalheiro EA, Junior JA, Mazzacoratti MG (2008) The renin–angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis. Epilepsia 49:1348–1357
  PubMed CAS Google Scholar
• Pereira MG, Becari C, Oliveira JA, Salgado MC, Garcia-Cairasco N, Costa-Neto CM (2010) Inhibition of the renin–angiotensin system prevents seizures in a rat model of epilepsy. Clin Sci (Lond) 119:477–482
  CAS Google Scholar
• Sarro GD, Paola ED, Gratteri S, Gareri P, Rispoli V, Siniscalchi A, Tripepi G, Gallelli L, Citraro R, Russo E (2012) Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res 65:285–296
  PubMed Google Scholar
• Gouveia TL, Frangiotti MI, de Brito JM, de Castro Neto EF, Sakata MM, Febba AC, Casarini DE, Amado D, Cavalheiro EA, Almeida SS, Manchini MT, Araujo RC, Jr Silva JA, Naffah-Mazzacoratti MG (2012) The levels of renin–angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Neurochem Int 61:54–62
  PubMed CAS Google Scholar
• Tchekalarova J, Kambourova T, Georgiev V (2001) Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors. Brain Res Bull 56:87–91
  PubMed CAS Google Scholar
• De Bundel D, Smolders I, Vanderheyden P, Michotte Y (2008) Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy. CNS Neurosci Ther 14:315–339
  PubMed Google Scholar
• Tchekalarova J, Georgiev V (2005) Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci 76:955–970
  PubMed CAS Google Scholar
• Georgiev VP, Lazarova MB, Petkov VD, Kambourova TS (1986) Interactions between angiotensin II, GABA and diazepam in convulsive seizures. Neuropeptides 7:329–336
  PubMed CAS Google Scholar
• Georgiev VP, Lazarova MB, Kambourova TS (1995) Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice. Neuropeptides 28:29–34
  PubMed CAS Google Scholar
• Georgiev VP, Lazarova MB, Kambourova TS (1996) Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice. Neuropeptides 30:401–404
  PubMed CAS Google Scholar
• Oz M, Yang KH, O'donovan MJ, Renaud LP (2005) Presynaptic angiotensin II AT1 receptors enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral horn neurons in neonatal rat spinal cord. J Neurophysiol 94:1405–1412
  PubMed CAS Google Scholar
• Loyens E, Schallier A, Chai SY, De Bundel D, Vanderheyden P, Michotte Y, Smolders I (2011) Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures. Seizure 20:602–605
  PubMed CAS Google Scholar
• Stragier B, Clinckers R, Meurs A, De Bundel D, Sarre S, Ebinger G, Michotte Y, Smolders I (2006) Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J Neurochem 98:1100–1113
  PubMed CAS Google Scholar
• Georgiev V, Gyorgy L, Getova D, Markovska V (1985) Some central effects of angiotensin II. Interactions with dopaminergic transmission. Acta Physiol Pharmacol Bulg 11:19–26
  PubMed CAS Google Scholar
• Tchekalarova J, Sotiriou E, Georgiev V, Kostopoulos G, Angelatou F (2005) Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV. Brain Res 1032:94–103
  PubMed CAS Google Scholar
• Gall CM (1988) Localization and seizure-induced alterations of opioid peptides and CCK in the hippocampus. NIDA Res Monogr 82:12–32
  PubMed CAS Google Scholar
• Wyeth MS, Zhang N, Mody I, Houser CR (2010) Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy. J Neurosci 30:8993–9006
  PubMed CAS PubMed Central Google Scholar
• Wyeth MS, Zhang N, Houser CR (2012) Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals. Neuroscience 202:371–383
  PubMed CAS PubMed Central Google Scholar
• Iadarola MJ, Sherwin AL (1991) Alterations in cholecystokinin peptide and mRNA in actively epileptic human temporal cortical foci. Epilepsy Res 8:58–63
  PubMed CAS Google Scholar
• Zetler G (1980) Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam. Eur J Pharmacol 65:297–300
  PubMed CAS Google Scholar
• Kadar T, Pesti A, Penke B, Telegdy G (1984) Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration. Neuropharmacology 23:955–961
  PubMed CAS Google Scholar
• Deng PY, Xiao Z, Jha A, Ramonet D, Matsui T, Leitges M, Shin HS, Porter JE, Geiger JD, Lei S (2010) Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability. J Neurosci 30:5136–5148
  PubMed CAS PubMed Central Google Scholar
• Deng PY, Lei S (2006) Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats. J Physiol 572:425–442
  PubMed CAS PubMed Central Google Scholar
• Gall C, Lauterborn J, Isackson P, White J (1990) Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog Brain Res 83:371–390
  PubMed CAS Google Scholar
• Gall C (1988) Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers. J Neurosci 8:1852–1862
  PubMed CAS Google Scholar
• Sperk G, Wieser R, Widmann R, Singer EA (1986) Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience 17:1117–1126
  PubMed CAS Google Scholar
• Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O (1985) Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res 338:289–295
  PubMed CAS Google Scholar
• Shulkes A, Harris QL, Lewis SJ, Vajda JE, Jarrott B (1988) Regional brain concentrations of neurotensin following amygdaloid kindled and cortical suprathreshold stimulation-induced seizures in the rat. Neuropeptides 11:77–81
  PubMed CAS Google Scholar
• Lee HK, Zhang L, Smith MD, White HS, Bulaj G (2009) Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy. ChemMedChem 4:400–405
  PubMed Google Scholar
• Robertson CR, Flynn SP, White HS, Bulaj G (2011) Anticonvulsant neuropeptides as drug leads for neurological diseases. Nat Prod Rep 28:741–762
  PubMed CAS Google Scholar
• Li S, Geiger JD, Lei S (2008) Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiol 99:2134–2143
  PubMed CAS Google Scholar
• Green BR, White KL, McDougle DR, Zhang L, Klein B, Scholl EA, Pruess TH, White HS, Bulaj G (2010) Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities. J Pept Sci 16:486–495
  PubMed CAS Google Scholar
• Koneru A, Satyanarayana S, Rizwan S (2009) Endogenous opioids: their physiological role and receptors. Glob J Pharmacol 3:149–153
  Google Scholar
• Kanamatsu T, Obie J, Grimes L, McGinty JF, Yoshikawa K, Sabol S, Hong JS (1986) Kainic acid alters the metabolism of Met5-enkephalin and the level of dynorphin A in the rat hippocampus. J Neurosci 6:3094–3102
  PubMed CAS Google Scholar
• McGinty JF, Kanamatsu T, Obie J, Dyer RS, Mitchell CL, Hong JS (1986) Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus. Neurosci Lett 71:31–36
  PubMed CAS Google Scholar
• Rocha LL, Evans CJ, Maidment NT (1997) Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis. J Neurochem 68:616–624
  PubMed CAS Google Scholar
• Mazarati A, Liu H, Wasterlain C (1999) Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience 89:167–173
  PubMed CAS Google Scholar
• Pirker S, Gasser E, Czech T, Baumgartner C, Schuh E, Feucht M, Novak K, Zimprich F, Sperk G (2009) Dynamic up-regulation of prodynorphin transcription in temporal lobe epilepsy. Hippocampus 19:1051–1054
  PubMed CAS PubMed Central Google Scholar
• Hammers A, Asselin MC, Hinz R, Kitchen I, Brooks DJ, Duncan JS, Koepp MJ (2007) Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain 130:1009–1016
  PubMed Google Scholar
• McDermott CM, Schrader LA (2011) Activation of kappa opioid receptors increases intrinsic excitability of dentate gyrus granule cells. J Physiol 589:3517–3532
  PubMed CAS PubMed Central Google Scholar
• Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C (2007) Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain 130:1017–1028
  PubMed Google Scholar
• Simmons ML, Chavkin C (1996) Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 39:145–196
  PubMed CAS Google Scholar
• Wheless JW, Gibson PA, Rosbeck KL, Hardin M, O'Dell C, Whittemore V, Pellock JM (2012) Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatr 12:108
  PubMed PubMed Central Google Scholar
• Baram TZ (2007) Models for infantile spasms: an arduous journey to the Holy Grail. Ann Neurol 61:89–91
  PubMed CAS PubMed Central Google Scholar
• Brunson KL, Eghbal-Ahmadi M, Baram TZ (2001) How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev 23:533–538
  PubMed CAS PubMed Central Google Scholar
• Baram TZ, Hirsch E, Snead OC III, Schultz L (1992) Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 31:488–494
  PubMed CAS PubMed Central Google Scholar
• Baram TZ, Chalmers DT, Chen C, Koutsoukos Y, De Souza EB (1997) The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 770:89–95
  PubMed CAS PubMed Central Google Scholar
• Wang W, Dow KE, Fraser DD (2001) Elevated corticotropin releasing hormone/corticotropin releasing hormone-R1 expression in postmortem brain obtained from children with generalized epilepsy. Ann Neurol 50:404–409
  PubMed CAS Google Scholar
• Aldenhoff JB, Gruol DL, Rivier J, Vale W, Siggins GR (1983) Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221:875–877
  PubMed CAS Google Scholar
• Hollrigel GS, Chen K, Baram TZ, Soltesz I (1998) The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 84:71–79
  PubMed CAS PubMed Central Google Scholar
• Avishai-Eliner S, Yi SJ, Baram TZ (1996) Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 91:159–163
  PubMed CAS PubMed Central Google Scholar
• Baram TZ, Schultz L (1991) Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61:97–101
  PubMed CAS PubMed Central Google Scholar
• Wang W, Murphy B, Dow KE, David AR, Fraser DD (2004) Systemic adrenocorticotropic hormone administration down-regulates the expression of corticotropin-releasing hormone (CRH) and CRH-binding protein in infant rat hippocampus. Pediatr Res 55:604–610
  PubMed CAS Google Scholar
• Jaseja H, Jaseja B, Badaya S, Tonpay P (2012) Superior therapeutic efficacy of adrenocorticotrophic hormone (ACTH) in infantile spasms: emerging evidence. Epilepsy Behav 25:250
  PubMed Google Scholar
• Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ (2001) Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol 49:304–312
  PubMed CAS PubMed Central Google Scholar
• Nagamitsu S, Matsuishi T, Yamashita Y, Shimizu T, Iwanaga R, Murakami Y, Miyazaki M, Hashimoto T, Kato H (2001) Decreased cerebrospinal fluid levels of beta-endorphin and ACTH in children with infantile spasms. J Neural Transm 108:363–371
  PubMed CAS Google Scholar
• Baram TZ, Mitchell WG, III Snead OC, Horton EJ, Saito M (1992) Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 42:1171–1175
  PubMed CAS PubMed Central Google Scholar
• Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani AR (1985) Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia 26:446–449
  PubMed CAS Google Scholar
• Hauger RL, Irwin MR, Lorang M, Aguilera G, Brown MR (1993) High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization. Brain Res 616:283–292
  PubMed CAS Google Scholar
• Shumiloff NA, Lam WM, Manasco KB (2013) Adrenocorticotropic hormone for the treatment of West syndrome in children. Ann Pharmacother 47:744–754
  PubMed Google Scholar
• O'Dowd BF, Lee DK, Huang W, Nguyen T, Cheng R, Liu Y, Wang B, Gershengorn MC, George SR (2000) TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol Endocrinol 14:183–193
  PubMed Google Scholar
• Knoblach SM, Kubek MJ (1997) Changes in thyrotropin-releasing hormone levels in hippocampal subregions induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 76:97–104
  PubMed CAS Google Scholar
• Knoblach SM, Kubek MJ (1997) Increases in thyrotropin-releasing hormone messenger RNA expression induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling. Neuroscience 76:85–95
  PubMed CAS Google Scholar
• Kubek MJ, Meyerhoff JL, Hill TG, Norton JA, Sattin A (1985) Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain. Life Sci 36:315–320
  PubMed CAS Google Scholar
• Takeuchi Y, Matsushita H, Kawano H, Sakai H, Yoshimoto K, Sawada T (1999) TRH increases cerebrospinal fluid concentration of kynurenine. Neuroreport 10:3601–3603
  PubMed CAS Google Scholar
• Deng PY, Porter JE, Shin HS, Lei S (2006) Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol 577:497–511
  PubMed CAS PubMed Central Google Scholar
• Khomane KS, Meena CL, Jain R, Bansal AK (2011) Novel thyrotropin-releasing hormone analogs: a patent review. Expert Opin Ther Pat 21:1673–1691
  PubMed CAS Google Scholar
• Facchinetti F, Nalin A, Petraglia F, Galli V, Genazzani AR (1985) Reduced ACTH, while normal beta-endorphin CSF levels in early epileptic encephalopathies. Peptides 6:31–33
  PubMed CAS Google Scholar
• Henriksen SJ, Bloom FE, McCoy F, Ling N, Guillemin R (1978) Beta-endorphin induces nonconvulsive limbic seizures. Proc Natl Acad Sci U S A 75:5221–5225
  PubMed CAS PubMed Central Google Scholar
• Cain DP, Boon F, Corcoran ME (1990) Involvement of multiple opiate receptors in opioid kindling. Brain Res 517:236–244
  PubMed CAS Google Scholar
• Bing G, Wilson B, Hudson P, Jin L, Feng Z, Zhang W, Bing R, Hong JS (1997) A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc Natl Acad Sci U S A 94:9422–9427
  PubMed CAS PubMed Central Google Scholar
• Rees H, Ang LC, Shul DD, George DH, Begley H, McConnell T (1994) Increase in enkephalin-like immunoreactivity in hippocampi of adults with generalized epilepsy. Brain Res 652:113–119
  PubMed CAS Google Scholar
• Carrillo E, Fuente T, Laorden ML (1992) Hyperthermia-induced seizures alter the levels of methionine-enkephalin in immature rat brain. Neuropeptides 21:139–142
  PubMed CAS Google Scholar
• Laorden ML, Olaso MJ, Miralles FS, Puig MM (1985) Cerebrospinal fluid leucine-enkephalin-like levels in febrile convulsions. Methods Find Exp Clin Pharmacol 7:75–77
  PubMed CAS Google Scholar
• Tanaka T, Takeshita H, Kawahara R, Hazama H (1989) Chemical kindling with Met-enkephalin and transfer between chemical and electrical kindling. Epilepsy Res 3:214–221
  PubMed CAS Google Scholar
• Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH (1993) Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267:888–895
  PubMed CAS Google Scholar
• Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T (2000) Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res 862:120–126
  PubMed CAS Google Scholar
• Grecksch G, Becker A, Schroeder H, Hollt V (1999) Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats. Naunyn Schmiedebergs Arch Pharmacol 360:151–156
  PubMed CAS Google Scholar
• Schroeder H, Becker A, Grecksch G, Schroeder U, Hoellt V (1998) The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats. Brain Res 811:40–46
  PubMed CAS Google Scholar
• Lupica CR (1995) Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J Neurosci 15:737–749
  PubMed CAS Google Scholar
• Sperk G, Marksteiner J, Saria A, Humpel C (1990) Differential changes in tachykinins after kainic acid-induced seizures in the rat. Neuroscience 34:219–224
  PubMed CAS Google Scholar
• Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R, Wasterlain CG (1999) Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc Natl Acad Sci U S A 96:12096–12101
  PubMed CAS PubMed Central Google Scholar
• Zachrisson O, Lindefors N, Brene S (1998) A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Res Mol Brain Res 60:291–295
  PubMed CAS Google Scholar
• Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci U S A 96:5286–5291
  PubMed CAS PubMed Central Google Scholar
• Kato Y, Igarashi N, Hirasawa A, Tsujimoto G, Kobayashi M (1995) Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain. Differentiation 59:163–169
  PubMed CAS Google Scholar
• Richmond CA (2003) The role of arginine vasopressin in thermoregulation during fever. J Neurosci Nurs 35:281–286
  PubMed Google Scholar
• Kasting NW, Veale WL, Cooper KE, Lederis K (1981) Vasopressin may mediate febrile convulsions. Brain Res 213:327–333
  PubMed CAS Google Scholar
• Sun Q, Pretel S, Applegate CD, Piekut DT (1996) Oxytocin and vasopressin mRNA expression in rat hypothalamus following kainic acid-induced seizures. Neuroscience 71:543–554
  PubMed CAS Google Scholar
• Iwanaga M, Ohno M, Katoh A, Ohbuchi T, Ishikura T, Fujihara H, Nomura M, Hachisuka K, Ueta Y (2011) Upregulation of arginine vasopressin synthesis in the rat hypothalamus after kainic acid-induced seizures. Brain Res 1424:1–8
  PubMed CAS Google Scholar
• Kruse H, Van Wimersma Greidanus TB, De Wied D (1977) Barrel rotation induced by vasopressin and related peptides in rats. Pharmacol Biochem Behav 7:311–313
  PubMed CAS Google Scholar
• Abood LG, Knapp R, Mitchell T, Booth H, Schwab L (1980) Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J Neurosci Res 5:191–199
  PubMed CAS Google Scholar
• Croiset G, De Wied D (1997) Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. Brain Res 759:18–23
  PubMed CAS Google Scholar
• Gulec G, Noyan B (2002) Arginine vasopressin in the pathogenesis of febrile convulsion and temporal lobe epilepsy. Neuroreport 13:2045–2048
  PubMed CAS Google Scholar
• Murase T, Kondo K, Otake K, Oiso Y (1993) Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats. Neuroendocrinology 57:1092–1096
  PubMed CAS Google Scholar
• Chepurnova NE, Ponomarenko AA, Chepurnov SA (2002) Peptidergic mechanisms of hyperthermia-evoked convulsions in rats in early postnatal ontogenesis. Neurosci Behav Physiol 32:505–511
  PubMed CAS Google Scholar
• Nomura M, Ueta Y, Hannibal J, Serino R, Yamamoto Y, Shibuya I, Matsumoto T, Yamashita H (2000) Induction of pituitary adenylate cyclase-activating polypeptide mRNA in the medial parvocellular part of the paraventricular nucleus of rats following kainic-acid-induced seizure. Neuroendocrinology 71:318–326
  PubMed CAS Google Scholar
• Meierkord H, Shorvon S, Lightman SL (1994) Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure. Acta Neurol Scand 90:73–77
  PubMed CAS Google Scholar
• Mens WB, Van Wimersma Greidanus TB (1982) Hypophyseal hormone levels in blood and cerebrospinal fluid in response to histamine and pentylenetetrazol. Neuroendocrinology 35:418–423
  PubMed CAS Google Scholar
• Piekut DT, Pretel S, Applegate CD (1996) Activation of oxytocin-containing neurons of the paraventricular nucleus (PVN) following generalized seizures. Synapse 23:312–320
  PubMed CAS Google Scholar
• Greenwood RS, Fan Z, Meeker R (1997) Persistent elevation of corticotrophin releasing factor and vasopressin but not oxytocin mRNA in the rat after kindled seizures. Neurosci Lett 224:66–70
  PubMed CAS Google Scholar
• Carter DA, Murphy D (1993) Acute down-regulation of oxytocin and vasopressin mRNA levels following metrazole-induced seizure in the rat. Neurosci Lett 160:135–138
  PubMed CAS Google Scholar
• Kaplan E (1978) A generalized epileptiform convulsion after intra-amniotic prostaglandin with intravenous oxytocin infusion: a case report. S Afr Med J 53:27–29
  PubMed CAS Google Scholar
• Loyens E, Vermoesen K, Schallier A, Michotte Y, Smolders I (2012) Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors. Brain Res 1436:43–50
  PubMed CAS Google Scholar
• Erbas O, Yilmaz M, Korkmaz HA, Bora S, Evren V, Peker G (2013) Oxytocin inhibits pentylentetrazol-induced seizures in the rat. Peptides 40:141–144
  PubMed CAS Google Scholar
• Braida D, Donzelli A, Martucci R, Ponzoni L, Pauletti A, Sala M (2012) Neurohypophyseal hormones protect against pentylenetetrazole-induced seizures in zebrafish: role of oxytocin-like and V1a-like receptor. Peptides 37:327–333
  PubMed CAS Google Scholar
• Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B (2011) Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 69:875–882
  PubMed CAS Google Scholar
• Knigge KM, Wagner JE (1997) Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig. Peptides 18:1095–1097
  PubMed CAS Google Scholar
• Parks GS, Okumura SM, Gohil K, Civelli O (2010) Mice lacking melanin concentrating hormone 1 receptor are resistant to seizures. Neurosci Lett 484:104–107
  PubMed CAS PubMed Central Google Scholar
• Palasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, Bajor G (2012) Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 46:105–112
  PubMed CAS Google Scholar
• Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, Sahin I, Karatas F, Yoldas T, Barim AO, Kendir Y (2009) Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 328:49–56
  PubMed CAS Google Scholar
• Aydin S, Dag E, Ozkan Y, Arslan O, Koc G, Bek S, Kirbas S, Kasikci T, Abasli D, Gokcil Z, Odabasi Z, Catak Z (2011) Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients. Peptides 32:1276–1280
  PubMed CAS Google Scholar
• Liu Z, Wang F, Li ZZ, Qi JH, Xu WZ, Zhang PS, Sun T (2011) Expression of neuropeptides ghrelin and nesfatin-1 in kainic acid kindling rats. Zhonghua Yi Xue Za Zhi 91:496–500
  PubMed CAS Google Scholar
• Romualdi P, Lesa G, Donatini A, Balboni G, Tomatis R, Ferri S (1992) Alterations in vasoactive intestinal polypeptide-related peptides after pentylenetetrazole-induced seizures in rat brain. Eur J Pharmacol 229:149–153
  PubMed CAS Google Scholar
• Marksteiner J, Sperk G, Maas D (1989) Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacol 339:173–177
  PubMed CAS Google Scholar
• Ko FJ, Chiang CH, Liu WJ, Chiang W (1991) Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders. Gaoxiong Yi Xue Ke Xue Za Zhi 7:391–397
  PubMed CAS Google Scholar
• de Lanerolle NC, Gunel M, Sundaresan S, Shen MY, Brines ML, Spencer DD (1995) Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy. Brain Res 686:182–193
  PubMed Google Scholar
• Bulaj G, Green BR, Lee HK, Robertson CR, White K, Zhang L, Sochanska M, Flynn SP, Scholl EA, Pruess TH, Smith MD, White HS (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. J Med Chem 51:8038–8047
  PubMed CAS Google Scholar
• Veronesi MC, Kubek DJ, Kubek MJ (2007) Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat. Epilepsia 48:2280–2286
  PubMed CAS Google Scholar
• Kubek MJ, Domb AJ, Veronesi MC (2009) Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics 6:359–371
  PubMed CAS Google Scholar
• Noé F, Vaghi V, Balducci C, Fitzsimons H, Bland R, Zardoni D, Sperk G, Carli M, During MJ, Vezzani A (2010) Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus. Gene Ther 17:643–652
  PubMed Google Scholar
• Sorensen AT, Kokaia M (2013) Novel approaches to epilepsy treatment. Epilepsia 54:1–10
  PubMed Google Scholar
• McCown TJ (2010) The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy. Drug News Perspect 23:281–286
  PubMed CAS Google Scholar
• Foti SB, Samulski RJ, McCown TJ (2009) Delivering multiple gene products in the brain from a single adeno-associated virus vector. Gene Ther 16:1314–1319
  PubMed CAS PubMed Central Google Scholar
• Pitkänen A, Schwartzkroin PA, Moshé SL (2006) Models of seizures and epilepsy. Elsevier Academic Press, Burlington
  Google Scholar
• Wan RQ, Noguera EC, Weiss SR (1998) Anticonvulsant effects of intra-hippocampal injection of TRH in amygdala kindled rats. Neuroreport 9:677–682
  PubMed CAS Google Scholar